Shanghai Haohai Biotech files for HK IPO

Hospital2
By Christina Khouri
16 Dec 2014

Biomedical material manufacturer Shanghai Haohai Biological Technology is looking to list in Hong Kong.

Shanghai Haohai researches, develops, manufactures and sells absorbable materials — non-toxic materials used in surgeries that can be absorbed by the human body. The company, which filed a preliminary prospectus with the Hong Kong Stock Exchange on December 15, distributes its products to hospitals and medical institutions ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial

Want to learn more? View subscription options